th
An interactive workshop for people from diverse backgrounds to discuss issues, share ideas and look for opportunities for collaboration. There will be discussion time after each presentation and opportunities for networking. We plan to circulate details of network members’ interests and expertise in order to help generate cross disciplinary research, etc.
9am Registration
9.15am Background – the complexities of cancer prevention research
Tony Howell, Professor of Medical Oncology, Christie Hospital and University of Manchester
9.30 Cancer prevention research – rationale for and aims of network
Dr Andrew Renehan, Christie Hospital NHS Trust
9.45
10.00
An example of a successful research network
Discussion group sessions covering five questions – Chair: Gareth Evans, Professor of
Medical Genetics and Cancer Epidemiology
10.45





What is the cancer prevention research community currently in the UK and how should it evolve/change?
What is the scope of the Network?
Manchester and a cancer prevention research network?
What are the key cancer prevention research questions?
Brain storming – routes for funding. A NIHR programme grant application for 2008?
Coffee
11.00 Feedback and discussion from sessions
12.00 Summarising discussions and action plans for the future
Chris Todd Professor of Primary Care and Community Health, School of Nursing, Midwifery and
Social work with Dr Andrew Renehan and Prof Tony Howell.
12.45pm Lunch
2.00pm Close of Meeting
****
This is a joint initiative between the Greater Manchester Research Alliance and the Institute of
Health Sciences at the University of Manchester www.manchester.ac.uk/ihs www.gmsha.nhs.uk/gmra/
Please complete the enclosed booking form if you’d like to attend – spaces are filling up fast .

Who should attend?
This is an interdisciplinary network with academics, clinicians (primary care and acute sector with interests in all cancers), health professionals, policy makers and representatives from the voluntary sector. Network members have with interests and expertise in laboratory science, cancer epidemiology, health economics, health policy, medical genetics, nursing, patient/consumer representation, primary care, psychology, social marketing, social care and statistics.
About the interdisciplinary advisory panel
Co-lead Professor Tony Howell - Professor of Medical Oncology, University of Manchester and R&D Director
Christie Hospital - anthony.howell@christie.nhs.uk
Tel: 0161 446 8037
Co-lead Dr Andrew Renehan, Senior Lecturer in Cancer Studies and Surgery, University of Manchester
ARenehan@picr.man.ac.uk
Professor Steve Birch (health economics representative), School of Community based medicine UoM and
McMaster University Canada.
Dr Iain Buchan (cancer epidemiology and statistics representative), Director North west Institute for Biohealth
Informatics (NIBHI), UoM
Gareth Evans Professor in Medical Genetics and Cancer, CMMC and University of Manchester
Rebecca Jones (IHS) – Rebecca.l.jones@manchester.ac.uk - www.manchester.ac.uk/ihs
Henry Kitchener, Professor of Gynaecological Oncology, R&D Director, CMMC and Research School of Cancer and Imaging, University of Manchester
Diane Parker, Professor of Applied Social Psychology, School of Psychological Sciences, University of
Manchester
Chris Todd, Professor of Primary Care & Community Health, School of Nursing Midwifery & Social Work,
University of Manchester
Dr Ian Watson (primary care and community representative), General Practioner
We also plan to appoint representatives from Health policy, Laboratory scientist, Patient/consumer representation, Social Marketing, Statistician and voluntary sector.
Possible topics covered include:
The scope of the CPRN encompasses research directly aimed at prevention interventions and related elements of aetiology. The focus is research aimed at primary prevention, leading to a reduction in cancer incidence, resulting in a reduction in mortality. The specific areas of research included are:



Diet and nutrition including obesity
Exposure to and screening for infectious agents and associated vaccine studies
Environmental risk factors including radiation and sunlight






Public health policy
Communication and intervention
Behaviours affecting cancer risk and strategies to modify behaviour e.g. alcohol
Genetic counselling and prevention interventions for “at-risk” populations
Surrogate markers (both in the circulation and at a tissue level) and cancer risk
Chemoprevention trials
Screening for and detection of tumours (but excluding screening mechanics research) 


Identification of genes involved in hereditary pre-disposition
Identification of low-penetrance genes and genetic predisposition studies.
These areas span four broad fields: basic science, health promotion, population and behavioural studies, and trials.
Join us if you have expertise in these areas and you would like to contribute to this exciting new initiative

I can attend the FREE workshop
Title
Name
Job Title / Role
Organisation
Contact address
Tel
Fax
Email
Any special requirements?
th
(please print or type)
Yes / No
Dietary/Access/etc
Would you like to join the Cancer
Prevention Research Network?
Yes / No
I am unable to attend but please keep me informed of developments
Yes / No
There is ample free parking at Chancellors Conference Centre – more information at: www.conference.manchester.ac.uk/chancellorshotelconferencecentre/location/
Please return the booking form ASAP to:
Maria Parker, PA to Prof Howell, CRUK Department of Medical Oncology, Christie Hospital NHS Foundation
Trust, Wilmslow Road, Manchester, M20 4BX
Tel: + 44 (0)161 446 8037 Fax: + 44 (0)161 446 8000 Email: maria.parker@christie.nhs.uk